These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings

Abbott Laboratories ABT reported better-than-expected first-quarter adjusted EPS results on Wednesday.Abbott Laboratories reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of$ 10.40 billion. The U.S. MedTech giant reported adjusted EPS of $1.09, beating the consensus of$ 1.07 and the management guidance of $1.05-$ 1.09."Once again, Abbott's diversified business model delivered top-tier sales and EPS growth," said Robert Ford, chairman and CEO of Abbott. ...